Epidemiology and Laboratory Capacity for Infectious Diseases (Elc) in Alaska
CFDA 93.323 — federal program obligations to Alaska
Total obligated
$137.7M
Awards
2
Place of performance Alaska plus CFDA 93.323 (ELC Infectious Disease) sums to $137,665,655.31 across 2 awards in USAspending.gov. two instruments against $137.7 million imply about $68.83 million per award. It is not Alaska SAMHSA treatment funding, not a nationwide 93.323 rollup, and not Alaska's entire federal spending. The join is a table intersection, not a ranking of states. Obligations are not outlays.
Key figures
- CFDA 93.323 shows $137,665,655.31 in Alaska obligations on 2 awards.
- The mean is about $68.83 million per award.
- Two awards are not two named laboratories.
- Alaska is a place-of-performance tag, not a lab, case, or named-grantee census.
- Figures are obligations, not outlays.
Two Alaska instruments on CFDA 93.323
CFDA 93.323 is titled EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES (ELC). Crossed with Alaska place of performance, obligations sum to $137,665,655.31 on 2 awards. The national 93.323 hub includes other states. Alaska’s spending hub includes other programs. Only this intersection is reported here. $137,665,655.31 is an obligation aggregate from USAspending.gov, not an outlay and not a count of Alaska public-health labs.
two awards is a thin CDC cooperative-agreement file with two large instruments. The join does not name recipients. Packet facts are $137,665,655.31, 2 awards, AK, and 93.323. Correlation is not causation. FEC donations do not fund this USAspending cell. Keep ELC Infectious Disease and Alaska together when reading $137,665,655.31.
ELC, not SAMHSA treatment services
SAMHSA PRNS (CFDA 93.243) is a treatment catalog, not this epidemiology-and-lab listing. Mixing 93.323 and 93.243 in Alaska would invent a combined public-health book. Mixing those series into $137,665,655.31 would invent a broader total than this cell contains. Facts available: Alaska, CFDA 93.323, $137,665,655.31, 2 awards. Lab names, pathogen lists, and cooperative-agreement IDs are unpublished.
The catalog title names Epidemiology And Laboratory Capacity For Infectious Diseases (Elc), not a ranking of Alaska health districts. Dividing $137,665,655.31 by 2 yields about $68.83 million per award. Unique recipients are unpublished. 2 is not a lab, case, or named-grantee census.
Full analysis: Epidemiology and Laboratory Capacity (ELC) in Alaska →
Questions
- How much ELC infectious-disease funding is obligated in Alaska?
- USAspending records $137,665,655.31 in CFDA 93.323 obligations with Alaska place of performance on 2 awards. That is the pair total, not an outlay. Keep Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) and Alaska together when citing $137,665,655.31. Original filings remain on USAspending.gov.
- Do 2 awards mean 2 Alaska laboratories?
- 2 is a USAspending award-record count, not a lab, case, or named-grantee census. The implied mean is about $68.83 million per award. Unique recipients are unpublished. 2 is a record count, not a person or facility census. Original filings remain on USAspending.gov.
- Is this Alaska's total federal public-health spending?
- No. This join is CFDA 93.323 only. SAMHSA PRNS uses CFDA 93.243 and sits on a separate Alaska program page. Nationwide 93.323 is not limited to Alaska. Obligations of $137,665,655.31 are not outlays. The overlay is the live ELC Infectious Disease–Alaska table.
- Has this ELC money already been spent on tests?
- No. $137,665,655.31 is an obligation sum. Outlays are a different USAspending series. Drawdowns can lag the federal obligation. This packet has no outlay total. Original filings remain on USAspending.gov for this 93.323 × AK pair. Original filings remain on USAspending.gov.
USAspending.gov CFDA program aggregates by place of performance state. Obligations are not outlays.
How this pair fits
Explore related views: National Epidemiology and Laboratory Capacity for Infectious Diseases (Elc) profile · All programs in Alaska · All spending in Alaska